Page last updated: 2024-08-17

penicillanic acid and Cirrhosis, Liver

penicillanic acid has been researched along with Cirrhosis, Liver in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cotton, F; Creteur, J; Gustot, T; Hites, M; Jacobs, F; Lheureux, O; Surin, R; Taccone, FS; Trepo, E; Vincent, JL; Wolff, F1
Chao, CM; Chiu, YH; Hou, CC; Lai, CC; Liu, WL1
Homann, C; Knudsen, JD; Moser, C; Novovic, S; Olsen, H; Semb, S1

Other Studies

3 other study(ies) available for penicillanic acid and Cirrhosis, Liver

ArticleYear
Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study.
    Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:7

    Topics: Aged; Anti-Bacterial Agents; Belgium; Case-Control Studies; Chromatography, High Pressure Liquid; Critical Illness; Databases, Factual; Drug Monitoring; Female; Humans; Liver Cirrhosis; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Thienamycins

2016
Biliary tract infection caused by Vibrio fluvialis in an immunocompromised patient.
    Infection, 2011, Volume: 39, Issue:5

    Topics: Abdominal Pain; Aged, 80 and over; Anti-Bacterial Agents; Bile Ducts, Intrahepatic; Choledocholithiasis; Diabetes Mellitus; Diagnosis, Differential; Female; Gallstones; Humans; Immunocompromised Host; Kidney Failure, Chronic; Liver Cirrhosis; Penicillanic Acid; Piperacillin; Risk Factors; Taiwan; Tazobactam; Treatment Outcome; Vibrio; Vibrio Infections; Vomiting

2011
First-line treatment with cephalosporins in spontaneous bacterial peritonitis provides poor antibiotic coverage.
    Scandinavian journal of gastroenterology, 2012, Volume: 47, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Cephalosporins; Denmark; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Male; Meropenem; Middle Aged; Mycoses; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Thienamycins

2012